Zobrazeno 1 - 9
of 9
pro vyhledávání: '"C. Martin Bunke"'
Autor:
Mark E. Bensink, Deborah Goldschmidt, Zheng-Yi Zhou, Kaijun Wang, Richard Lieblich, C. Martin Bunke
Publikováno v:
Kidney Medicine, Vol 6, Iss 2, Pp 100760- (2024)
Rationale & Objective: This study describes the epidemiology, characteristics, and clinical outcomes of patients with focal segmental glomerulosclerosis (FSGS)-attributed kidney failure in the US Renal Data System (USRDS) during 2008-2018, and health
Externí odkaz:
https://doaj.org/article/4b1ded3784244132af98948074b8a9de
Autor:
John S. Thompson, Donald E. Hricik, C. Martin Bunke, Mark D. Pescovitz, Raymond Pollak, M. Gerry Choc, David I. Min, Eva M. Vasquez, James B. Stinson, Judy Hyun Ju Jin, Jon B. Klein, Christopher L. Marsh, R. Wong, Duane G. Wombolt, Thomas Waid, Timothy L. Pruett, Gary Barone
Publikováno v:
Transplantation. 61:968-970
A 12-week, randomized, double-blind, multicenter pharmacokinetic study was conducted to compare the clinical safety and tolerability of cyclosporine capsules and oral solution for microemulsion and cyclosporine in 101 primary renal transplant recipie
Publikováno v:
Kidney international. 52(2)
Outcomes of single organism peritonitis in peritoneal dialysis: Gram negatives versus gram positives in the Network 9 Peritonitis Study. The use of the “peritonitis rate” in the management of patients undergoing peritoneal dialysis is assuming im
Publikováno v:
Clinical Pharmacology and Therapeutics. 33:66-72
We studied single-dose cefazolin (CFZ) and cephalexin (CPX) kinetics in continuous ambulatory peritoneal dialysis (CAPD) patients to establish therapeutic guidelines for two cephalosporins commonly used to treat peritonitis in these patients. CFZ, 10
Publikováno v:
Clinical Pharmacology and Therapeutics. 33:73-76
To establish elimination kinetics of mezlocillin in patients with hepatic insufficiency, we gave eight normal subjects and four patients with hepatic insufficiency and normal renal function a single 3-gm dose of mezlocillin by intravenous infusion. S
Publikováno v:
Clinical pharmacology and therapeutics. 34(1)
To establish therapeutic guidelines for tobramycin use in patients receiving continuous ambulatory peritoneal dialysis (CAPD), we studied tobramycin single-dose kinetics in CAPD patients. Tobramycin was studied after a 1.5-mg/kg dose given either int
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 3(2)
To establish therapeutic guidelines for the use of antibiotics in patients receiving continuous ambulatory peritoneal dialysis (CAPD), we studied the single-dose pharmacokinetics of cefazolin, tobramycin, and vancomycin given intravenously (IV) and i
Publikováno v:
Clinical pharmacology and therapeutics. 34(5)
To establish therapeutic guidelines for vancomycin usage in patients receiving continuous ambulatory peritoneal dialysis (CAPD), we studied single-dose kinetics of vancomycin in CAPD patients. Vancomycin was studied after a 10-mg/kg dose was given in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.